复苏性主动脉内球囊阻断(REBOA)作为非创伤性心脏骤停高级心血管生命支持辅助手段的作用
非创伤性心脏骤停死亡率极高,需考虑替代治疗。本文综述REBOA作为ACLS辅助手段的作用:主动脉阻断可减少心输出量分布的血管容积,从而增强心肌与脑灌注。自1980年代早期起大量动物研究显示,ACLS期间REBOA改善脑与冠脉灌注压,带来统计学显著的死亡率差异;若干人类病例系列重复了这些发现,提示该操作有效。但人类证据仅限于几个小型病例系列,亟需进一步研究。
要点
- 非创伤性心脏骤停死亡率极高,传统ACLS效果有限,需考虑替代辅助方法。
- REBOA通过减少心输出量分布的血管容积,增强心肌与脑灌注,可能提高患者恢复良好生活质量的可能性。
- 动物研究显示,ACLS期间REBOA改善脑与冠脉灌注压,并带来统计学显著的死亡率差异。
- 若干人类病例系列重复了动物研究发现,提示该操作有效,但人类证据仅限几个小型病例系列。
适用人群与场景
- 非创伤性心脏骤停患者,作为传统ACLS的辅助手段。
研究设计与关键结果
- 综述纳入动物研究(自1980年代早期起)和若干人类小型病例系列;动物研究显示ACLS期间REBOA改善脑与冠脉灌注压,带来统计学显著的死亡率差异;人类病例系列重复了这些发现,提示该操作有效。
证据类型、等级与局限
- 证据类型:综述,汇总动物研究与人类病例系列。
- 人类证据仅限于几个小型病例系列。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,若希望提高非创伤性心脏骤停的存活率,必须充分考虑替代治疗方法。
- 作者认为,REBOA作为ACLS辅助手段在动物研究中改善灌注压并降低死亡率,人类病例系列提示有效,但证据有限。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Non-traumatic cardiac arrest is a major public health problem that carries an extremely high mortality rate. If we hope to increase the survivability of this condition, it is imperative that alternative methods of treatment are given due consideration. Balloon occlusion of the aorta can be used as a method of circulatory support in the critically ill patient. Intra-aortic balloon pumps have been used to temporize patients in cardiogenic shock for decades. More recently, resuscitative endovascular balloon occlusion of the aorta (REBOA) has been utilized in the patient in hemorrhagic shock or cardiac arrest secondary to trauma. Aortic occlusion in non-traumatic cardiac arrest has the effect of reducing the vascular volume that the generated cardiac output is distributed across. This augments myocardial and cerebral perfusion, increasing the probability of a return to a good quality of life for the patient. This phenomenon has been the subject of numerous animal studies dating back to the early 1980s; however, the human evidence is limited to several small case series. Animal research has demonstrated improvements in cerebral and coronary perfusion pressure during ACLS that lead to statistically significant differences in mortality. Several case series in humans have replicated these findings, suggesting the efficacy of this procedure. The objectives of this review are to: 1) introduce the reader to REBOA 2) review the physiology of NTCA and examine the current limitations of traditional ACLS 3) summarize the literature regarding the efficacy and feasibility of aortic balloon occlusion to support traditional ACLS.
参考来源
- Daley J, Morrison JJ, Sather J, et al. The role of resuscitative endovascular balloon occlusion of the aorta (REBOA) as an adjunct to ACLS in non-traumatic cardiac arrest. Am J Emerg Med. 2017. PMID: 28117180. doi:10.1016/j.ajem.2017.01.010
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。